HIV among injecting drug users: Current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities

Don C. Des Jarlais, Kamyar Arasteh, Salaam Semaan, Evan Wood

Research output: Contribution to journalReview article


Purpose of review: To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs). Recent findings: Major research developments include a global assessment of HIV infection among IDUs and evidence of a transition from epidemics concentrated among IDUs to generalized, heterosexual epidemics in eastern Europe and Asia. Intervention research also includes several studies of supervised-injecting facilities. Methodological research includes respondent-driven sampling and the use of hepatitis C virus and herpes simplex virus-2 as biomarkers for injecting and sexual risk. Summary: There have been important advances in research during the past year, but HIV infection continues to spread rapidly across many areas of the world among IDUs and their nondrug-using sex partners.

Original languageEnglish (US)
Pages (from-to)308-313
Number of pages6
JournalCurrent Opinion in HIV and AIDS
Issue number4
StatePublished - Jul 1 2009



  • AIDS
  • Epidemiology
  • HIV
  • Injecting drug use
  • Respondent-driven sampling
  • Supervised-injecting facilities

ASJC Scopus subject areas

  • Immunology
  • Hematology
  • Oncology
  • Oncology(nursing)
  • Infectious Diseases
  • Virology

Cite this